糖尿病管理数字工具的作用,潜在益处和成本效益
Anders L Carlson1, Sameer Badlani2, Viral N Shah3
1International Diabetes Center, Minneapolis, Minnesota.
Clinical therapeutics
|June 10, 2025
概括
像智能胰岛素笔这样的数字糖尿病工具可以提高坚持和血糖控制. 虽然成本效益较高,但较新的设备需要更多关于有效性和安全性的研究才能得到广泛采用.
科学领域:
- 内分泌学 在内分泌学.
- 数字健康数字健康
- 卫生经济学 卫生经济学
背景情况:
- 糖尿病管理面临着重大的健康和财务负担.
- 自动胰岛素输送,持续血糖监测 (CGM) 和胰岛素的进步有所增加.
- 数字健康工具,包括智能胰岛素笔和可穿戴CGM,利用智能手机技术来增强糖尿病护理.
研究的目的:
- 审查目前在糖尿病护理管理中的未满足需求.
- 总结最新的FDA批准的胰岛素输送系统和数字工具的有效性和安全性.
- 调查这些数字工具对美国患者的经济和医疗保健好处.
主要方法:
- 从2014年到2023年在PubMed中进行文献搜索.
- 包括叙述性审查,系统审查,随机对照试验和成本效益分析.
主要成果:
- 在美国,有许多数字糖尿病设备,CGM和应用程序具有已公布的结果.
- CGM和持续皮下胰岛素输注 (CSII) 的安全性和有效性已经得到充分证实.
- 对于新的数字工具,如智能胰岛素笔的证据目前有限.
结论:
- 数字糖尿病医疗保健工具提供了公认的成本效益和潜在的医疗保健节省.
- 对于像智能胰岛素笔这样的新设备存在有限的临床研究.
- 进一步的研究对于将这些创新设备完全整合到糖尿病管理中至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
515
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Insulin: Dosing Regimen and Adverse Effects
155
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
155


